iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. trimmed its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 19.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,824 shares of the company’s stock after selling 2,606 shares during the quarter. Envestnet Asset Management Inc. owned 0.11% of iShares U.S. Pharmaceuticals ETF worth $711,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at $25,000. Union Bancaire Privee UBP SA purchased a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $42,000. Runnymede Capital Advisors Inc. purchased a new position in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $164,000. Sequoia Financial Advisors LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 19.1% during the 4th quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock worth $226,000 after acquiring an additional 550 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 11.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock worth $253,000 after purchasing an additional 356 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 2.1 %

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $66.79 on Friday. The company has a fifty day simple moving average of $67.55 and a 200-day simple moving average of $68.16. iShares U.S. Pharmaceuticals ETF has a 12-month low of $58.97 and a 12-month high of $73.28. The stock has a market cap of $574.39 million, a price-to-earnings ratio of 23.46 and a beta of 0.63.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.